Literature DB >> 3309169

Interaction of non-lytic beta-lactams with penicillin-binding proteins in Streptococcus pneumoniae.

R Hakenbeck1, S Tornette, N F Adkinson.   

Abstract

The monobactam aztreonam and the cephalosporin ceftazidime, beta-lactam antibiotics that possess the same side chain R1, showed unusual effects on exponentially growing pneumococci compared to other beta-lactams. Both antibiotics did not induce lysis even at concentrations up to 2 mg ml-1, values well above the respective MICs. However, morphological alterations and growth inhibition of the cells were observed at much lower concentrations. Binding to penicillin-binding proteins (PBPs) in vitro could be monitored directly by using anti-aztreonam antiserum and the Western blot technique. Both antibiotics showed high affinity for PBP 3, but had an extremely low affinity for PBP 2b. It is suggested that the failure to bind to PBP 2b is responsible for the failure to induce lysis in pneumococci.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3309169     DOI: 10.1099/00221287-133-3-755

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  29 in total

Review 1.  Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.

Authors:  S J Schrag; B Beall; S F Dowell
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Unusual septum formation in Streptococcus pneumoniae mutants with an alteration in the D,D-carboxypeptidase penicillin-binding protein 3.

Authors:  C Schuster; B Dobrinski; R Hakenbeck
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

3.  Crystallization and preliminary crystallographic analysis of the transpeptidase domain of penicillin-binding protein 2B from Streptococcus pneumoniae.

Authors:  Mototsugu Yamada; Takashi Watanabe; Nobuyoshi Baba; Takako Miyara; Jun Saito; Yasuo Takeuchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-03-21

4.  A novel resistance mechanism against beta-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase.

Authors:  T Grebe; J Paik; R Hakenbeck
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

5.  Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.

Authors:  Ozden Kocaoglu; Ho-Ching T Tsui; Malcolm E Winkler; Erin E Carlson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

6.  Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.

Authors:  Klaudia Kosowska-Shick; Pamela McGhee; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-02-23       Impact factor: 5.191

7.  An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.

Authors:  Ilka Zerfass; Regine Hakenbeck; Dalia Denapaite
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

8.  Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.

Authors:  Todd A Davies; Malcolm G P Page; Wenchi Shang; Ted Andrew; Malgosia Kania; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

9.  Biochemical characterization of Streptococcus pneumoniae penicillin-binding protein 2b and its implication in beta-lactam resistance.

Authors:  Estelle Pagliero; Laurent Chesnel; Julie Hopkins; Jacques Croizé; Otto Dideberg; Thierry Vernet; Anne Marie Di Guilmi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.

Authors:  Radoslaw Izdebski; Jens Rutschmann; Janusz Fiett; Ewa Sadowy; Marek Gniadkowski; Waleria Hryniewicz; Regine Hakenbeck
Journal:  Antimicrob Agents Chemother       Date:  2007-12-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.